Summary
Segmental analysis of left ventricular wall motion was performed in 80 patients with systemic sclerosis by echocardiography. Half of the cases showed normal wall motion. Eighteen of the 57 patients with limited cutaneous systemic sclerosis (31.6%) exhibited hypokinetic wall motion abnormalities, while five of the 23 cases with diffuse cutaneous systemic sclerosis (21.7%) had similar findings. The three cases showing akinesis also belonged to the limited scleroderma subgroup. Our findings show that hypokinetic wall motion abnormalities can be detected in a remarkably high proportion of cases with limited cutaneous systemic sclerosis.
Similar content being viewed by others
References
Clements, P.J., Lachenbruch, P.A., Furst, D.E., Paulus, H.E., Sterz, M.G. Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1991, 34, 1371–1380.
D'Angelo, W.A., Fries, J.F., Masi, A.T., Shulman, L.E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969, 46, 428–440.
Hegedüs I., Czirják L. Left ventricular wall thickness and disease duration in systemic sclerosis Postgrad Med J 1993, 69, 291–295.
Follansbee, W.P., Miller, T.R., Curtiss, E.I., et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990, 17, 656–662.
Follansbee, W.P., Curtiss, E.I., Medsger, T.A.J., et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984, 310, 142–148.
Hegedüs, I., Czirják, L. Septum and posterior wall thickness and disease duration in systemic sclerosis. J Intern Med 1991, 229, 383–384.
Alpert, M.A., Pressly, T.A., Mukerji, V., et al. Acute and longterm effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. Am J Cardiol 1991, 68, 1687–1691.
Wynn, J., Fineberg, N., Matzer, L., et al. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 1985, 110, 123–127.
Czirják, L., Nagy, Z., Szegedi, G. Survival analysis of 118 patients with systemic sclerosis. J Int Med 1993, 234, 335–337.
Heger, J.J., Weyman, A.E., Wann, L.S., Dillon, J.C., Feigenbaum, H. Cross-sectional echocardiography in acute myocardial infarction: detection and localisation of regional left ventricular asynergy. Circulation 1979, 60: 531–538.
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23, 581–590.
LeRoy, E.C., Black, C., Fleischmajer, R., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15, 202–205.
Czirják, L., Nagy, Z., Szegedi, G. Systemic sclerosis in the elderly. Clin Rheumatol 1992, 11, 483–485.
Czirják, L., Bokk, Å., Csontos, G., Lôrincz, G., Szegedi, G. Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol Stockh 1989, 69, 533–536.
Bulkley, B.H., Klacsmann, P.G., Hutchins, G.M. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J 1978, 95, 563–569.
Anvari, A., Graninger, W., Schneider, B., Sochor, H., Weber, H., Schmidinger, H. Cardiac involvement in systemic sclerosis. Arthritis Rheum 1992, 35, 1356–1361.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hegedüs, I., Czirják, L. Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol 14, 161–164 (1995). https://doi.org/10.1007/BF02214936
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02214936